No definition available.
Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)
C3_PANCREAS_NEUROENDOCRINE_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
199 |
4. Check minimum number of eventsNone |
199 |
5. Include endpointsNone |
199 |
6. Filter based on genotype QC (FinnGen only) |
199 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Neuroendocrine tumor and carcinoma of pancreas
- Malignant neoplasm of pancreas
- Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 199 | 94 | 105 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | 61.51 | 59.71 | 63.12 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 179
- Matched controls
- 1790
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
200.6
114.4
110
14
130
Kela drug reimbursment
Malignant tumour
+∞
114.1
97
*
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
+∞
82.9
73
*
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
+∞
62.2
56
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
54.4
54.5
64
18
A09AA02
ATC
multienzymes (lipase, protease etc.)
87.0
54.5
59
10
H01CB03
ATC
lanreotide; parenteral
+∞
52.8
48
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
51.6
47
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
51.6
47
*
L01BC06
ATC
capecitabine; oral
+∞
49.3
45
*
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
49.3
45
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
137.4
48.7
50
5
8249/3-C25.9
ICD-O-3
Neuroendocrine tumor, grade 2 of pancreas, NOS
+∞
48.1
44
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
48.1
44
*
L01AX03
ATC
temozolomide; systemic
+∞
45.8
42
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
43.5
40
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
41.3
38
*
H01CB02
ATC
octreotide; parenteral
+∞
39.0
36
*
A03FA01
ATC
metoclopramide; systemic, rectal
11.0
36.5
79
120
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
+∞
35.6
33
*
JN4BD
NOMESCO Finland
Extensive body CT
17.3
34.7
57
47
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
34.5
32
*
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
405.7
34.1
33
*
JN4CD
NOMESCO Finland
Very extensive body CT
49.3
32.8
39
10
JN3BD
NOMESCO Finland
Extensive abdominal CT
11.4
32.7
67
89
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
+∞
32.3
30
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
374.8
31.9
31
*
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
193.4
31.8
32
*
D76
ICPC
Malignant neoplasm pancreas
+∞
31.2
29
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
186.1
30.7
31
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
35.1
30.5
39
14
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
27.6
30.0
41
19
JN4AD
NOMESCO Finland
Body CT examination
19.7
28.7
44
29
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
+∞
25.6
24
*
JLC30
NOMESCO Finland
Pancreatoduodenectomy
288.6
25.4
25
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
57.2
25.1
29
6
JN3AD
NOMESCO Finland
Abdominal CT examination
11.5
24.6
48
55
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
24.5
23
*
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
24.5
23
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
39.6
24.2
30
9
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.7
22.8
49
67
TPH07
NOMESCO Finland
Cathetrisation of artery
8.7
22.5
52
80
JMA10
NOMESCO Finland
Transabdominal total splenectomy
+∞
22.4
21
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
11.9
22.1
42
45
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
14.3
22.0
38
33
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
+∞
21.3
20
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
22.8
20.3
29
15
WX408
NOMESCO Finland
General anesthesy, balanced
4.9
19.9
81
256
WZC30
NOMESCO Finland
Teaching
7.2
19.8
52
96
N02AA05
ATC
oxycodone; systemic
8.1
19.7
47
75
B01AB05
ATC
enoxaparin; parenteral
4.6
19.2
88
311
ZXE20
NOMESCO Finland
More than three and less than five hours
6.5
19.0
54
111
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
30.5
18.4
24
9
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
18.0
17
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
18.0
17
*
158
Kela drug reimbursment
Everolimus
+∞
18.0
17
*
197
Kela drug reimbursment
Sunitinib
+∞
18.0
17
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
198.9
17.9
18
*
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
70.4
17.1
19
*
H02AB02
ATC
dexamethasone; systemic
31.1
17.0
22
8
A04AA01
ATC
ondansetron; systemic, rectal
16.7
16.4
26
18
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.2
16.1
79
285
8249/3-C25.2
ICD-O-3
Neuroendocrine tumor, grade 2 of tail of pancreas
+∞
15.9
15
*
JLC00
NOMESCO Finland
Excision of lesion of pancreas
+∞
15.9
15
*
Z51.5
ICD-10 Finland
Palliative care
23.5
15.1
21
10
XX3DW
NOMESCO Finland
Time consuming IT work
9.0
15.0
32
42
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
14.8
14
*
8246/3-C25.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of pancreas, NOS
+∞
14.8
14
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
14.8
14
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
162.7
14.7
15
*
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
+∞
13.7
13
*
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
13.7
13
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
151.0
13.6
14
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.0
13.5
47
119
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
13.1
105
539
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
+∞
12.6
12
*
L01XE10
ATC
[U] everolimus; oral
+∞
12.6
12
*
JN7AN
NOMESCO Finland
Somatostatin receptor isotope imaging
+∞
12.6
12
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
139.4
12.6
13
*
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
16.2
12.1
19
13
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
50.3
12.1
14
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
50.3
12.1
14
*
JAH01
NOMESCO Finland
Laparoscopy
11.2
11.9
22
22
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
32.5
11.8
15
5
340
Kela drug reimbursment
Everolimus
+∞
11.6
11
*
8240/3-C25.2
ICD-O-3
Neuroendocrine tumor, NOS, of tail of pancreas
+∞
11.6
11
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
127.9
11.6
12
*
JKA20
NOMESCO Finland
Cholecystectomy
14.0
11.4
19
15
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
10.7
76
341
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
10.7
82
390
JAH00
NOMESCO Finland
Laparotomy
13.2
10.6
18
15
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
17.4
10.6
16
10
L01XE04
ATC
[U] sunitinib; oral
+∞
10.5
10
*
E16.10
ICD-10 Finland
Hyperinsulinism
+∞
10.5
10
*
T73
ICPC
Neoplasm endocrine other/unspecified
+∞
10.5
10
*
A79
ICPC
Malignancy NOS
+∞
10.5
10
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
34.8
10.5
13
*
WX402
NOMESCO Finland
General anaesthesia
4.2
10.2
41
118
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.7
10.0
47
156
B01AB10
ATC
tinzaparin; parenteral
7.2
9.6
23
36
UJK02
NOMESCO Finland
ERCP
13.4
9.6
16
13
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
31.9
9.5
12
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
9.5
9
*
103
Kela drug reimbursment
Diabetes, insulin-treated
2.8
9.3
74
355
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.8
9.2
81
411
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
38.8
9.1
11
*
A10AE04
ATC
insulin glargine; parenteral
4.1
8.9
35
99
SPAT1262
SPAT
Handing over of treatment supplies
3.2
8.8
52
203
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
12.5
8.7
15
13
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
17.4
8.7
13
8
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
17.4
8.7
13
8
A11CC03
ATC
alfacalcidol; systemic
13.7
8.5
14
11
8249/3-C25.0
ICD-O-3
Neuroendocrine tumor, grade 2 of head of pancreas
+∞
8.4
8
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
+∞
8.4
8
*
322
Kela drug reimbursment
Sunitinib
+∞
8.4
8
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
4.8
8.4
28
67
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.7
8.3
69
336
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
8.2
46
173
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
35.1
8.2
10
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
23.3
8.1
11
5
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
13.9
8.0
13
10
E21.0
ICD-10 Finland
Primary hyperparathyroidism
12.6
7.7
13
11
C61
ICD-10 Finland
Malignant neoplasm of prostate
83.4
7.5
8
*
106
Kela drug reimbursment
Hypoparathyroidism
83.4
7.5
8
*
T90
ICPC
Diabetes non-insulin dependent
2.6
7.3
64
315
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
+∞
7.3
7
*
8249/3-C25.1
ICD-O-3
Neuroendocrine tumor, grade 2 of body of pancreas
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
+∞
7.3
7
*
E13.8
ICD-10 Finland
Other specified diabetes mellitus, with unspecified complications
+∞
7.3
7
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
7.3
7
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
31.4
7.2
9
*
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
31.4
7.2
9
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.4
7.1
25
63
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.0
7.0
28
80
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
14.5
7.0
11
8
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
14.5
7.0
11
8
Z31.5
ICD-10 Finland
Genetic counselling
8.8
7.0
14
17
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
6.9
59
284
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
41.7
6.8
8
*
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
41.7
6.8
8
*
J01MA12
ATC
levofloxacin; systemic
2.8
6.8
48
209
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
23.5
6.7
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
6.5
49
221
BBA50
NOMESCO Finland
Total parathyroidectomy
72.3
6.5
7
*
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
72.3
6.5
7
*
A06AH03
ATC
naloxegol; oral
72.3
6.5
7
*
WF002
NOMESCO Finland
Radical radiotherapy
72.3
6.5
7
*
R4190
NOMESCO Finland
Nutritional therapy
8.7
6.5
13
16
ZXF10
NOMESCO Finland
Interruption caused by technical failure of equipment
+∞
6.3
6
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
6.3
6
*
V03AH01
ATC
diazoxide; systemic
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
8246/3-C25.2
ICD-O-3
Neuroendocrine carcinoma, NOS, of tail of pancreas
+∞
6.3
6
*
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
+∞
6.3
6
*
D44.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified
+∞
6.3
6
*
WW500
NOMESCO Finland
Blood transfusion
8.1
6.2
13
17
K83.0
ICD-10 Finland
Cholangitis
13.1
6.2
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
162
9
945.21
194.64
9.8
2.2
nmol/l
45.0
3.7
—
162
9
(4035726)
85
41
35.44
119.53
1.6
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
100
86
22.36
106.75
3.6
1.4
ug/l
5.2
2.6
1.10
81
65
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
58
12
67.80
102.83
4.4
1.3
ug/l
27.1
16.9
0.80
58
12
(3000570) Elastase.pancreatic [Mass/mass] in Stool
70
39
27.15
91.49
2.0
1.2
ug/g
198.5
320.5
2.51
59
22
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
59
33
24.99
76.31
3.3
1.4
u/ml
715.9
10.1
0.51
54
23
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
47
41
14.70
47.37
2.2
1.2
nmol/l
0.7
0.9
0.41
47
33
(3024561) Albumin [Mass/volume] in Serum or Plasma
156
636
7.72
37.46
10.5
3.6
g/l
34.7
35.8
2.09
151
591
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
136
507
6.31
35.54
5.3
2.2
u/l
75.3
57.5
0.47
130
467
(3032080) INR in Blood by Coagulation assay
149
602
6.87
35.48
11.5
7.8
inr
1.2
1.3
0.42
50
159
(3035637) Corticotropin [Mass/volume] in Plasma
23
13
19.87
28.59
2.5
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
146
670
5.43
27.25
11.8
5.2
mmol/l
1.2
1.2
0.74
141
597
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
152
734
5.53
26.22
14.4
5.7
mmol/l
1.2
1.2
0.59
124
636
(3018418) pH of Serum or Plasma
111
434
4.52
24.97
8.6
3.4
ph
7.4
7.4
0.06
31
66
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
137
635
4.72
24.24
5.9
3.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
58
145
5.23
22.85
3.9
2.0
u/l
126.6
31.9
0.94
53
119
(3013826) Glucose [Moles/volume] in Serum or Plasma
164
911
5.55
21.87
9.2
4.1
mmol/l
7.3
6.7
2.88
159
840
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
65
186
4.70
21.63
4.7
2.4
umol/l
8.5
7.1
0.21
57
161
(3023368) Bacteria identified in Blood by Culture
94
386
3.72
18.49
6.8
4.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
100
431
3.65
18.20
3.0
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
102
475
3.35
15.90
10.5
2.1
mmol/l
2.4
2.4
0.20
96
389
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
44
118
4.50
15.52
6.0
4.6
ng/l
60.7
84.7
1.56
37
102
(3013650) Neutrophils [#/volume] in Blood by Automated count
147
869
3.65
15.16
21.6
6.2
e9/l
4.2
4.3
0.08
138
762
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
17
18
10.23
14.53
2.3
1.8
u/ml
689.0
208.3
0.29
17
18
(40758558) Short blood count panel - Blood
79
347
3.12
13.09
16.7
4.7
—
—
—
0
0
(3002256) Pathology report gross observation
43
128
4.01
13.09
1.5
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
99
496
2.98
12.94
8.3
5.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
53
187
3.50
12.54
2.5
2.4
%
18.6
23.5
1.88
45
160
(3020891) Body temperature
27
58
5.23
12.30
6.4
3.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
74
324
3.04
12.20
2.5
1.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
35
95
4.26
12.01
8.3
4.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
34
91
4.30
11.88
11.4
6.5
mmol/l
25.3
24.9
0.38
34
86
(3003396) Base excess in Arterial blood by calculation
47
166
3.40
11.00
8.4
6.5
mmol/l
1.8
1.4
0.25
41
131
(3006315) Basophils [#/volume] in Blood
128
782
2.78
10.84
9.8
5.1
e9/l
0.0
0.0
0.14
114
676
(3021589) Normoblasts [#/volume] in Blood
117
688
2.70
10.62
21.4
7.8
e9/l
0.0
0.0
1.14
103
553
(3001604) Monocytes [#/volume] in Blood
127
778
2.75
10.61
9.9
5.1
e9/l
0.6
0.6
1.28
113
670
(40768804) Tissue Pathology biopsy report
94
498
2.68
10.51
2.6
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
46
165
3.33
10.47
8.5
6.5
kpa
13.7
11.7
1.31
46
160
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
46
165
3.33
10.47
8.5
6.5
kpa
5.3
5.2
0.17
46
158
(3013115) Eosinophils [#/volume] in Blood
129
803
2.72
10.33
9.9
5.3
e9/l
0.2
0.2
0.39
117
706
(3019198) Lymphocytes [#/volume] in Blood
128
794
2.72
10.32
10.0
5.1
e9/l
2.0
1.9
0.55
116
695
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
21
7.64
10.28
2.1
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
21
7.64
10.28
2.2
1.4
nmol/l
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
9
17.89
10.04
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
11
10.53
9.63
3.9
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
21
7.10
9.02
1.0
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
94
545
2.37
8.15
3.2
3.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
36
136
3.01
7.39
5.3
2.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
56
267
2.53
7.37
8.2
2.0
mmol/l
2.5
2.4
2.12
49
224
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
35
134
2.96
7.01
3.7
3.4
ng/l
136.8
232.6
1.02
28
125
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
65
342
2.34
6.83
2.7
2.0
mg/l
3.0
3.0
0.03
57
281
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
33
4.83
6.57
1.9
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
87
526
2.16
6.46
3.0
3.2
mmol/l
6.7
7.8
1.72
75
447
(3002582) Erythrocytes [#/volume] in Urine
79
461
2.18
6.41
3.5
3.0
e6/l
12.7
86.1
2.00
63
350
(36304419) Bacteria [Presence] in Urine
72
406
2.21
6.35
2.8
2.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
31
4.78
6.08
2.4
2.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
47
228
2.39
5.85
2.3
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
106
2.91
5.69
4.0
3.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
72
423
2.10
5.61
3.2
2.9
e6/l
0.4
0.5
0.24
57
307
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
82
507
2.05
5.56
3.3
3.0
ng/l
726.0
1072.7
0.58
73
417
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
147
1126
2.17
5.45
6.0
3.0
u/l
89.3
49.5
1.38
141
1049
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
44
3.87
5.32
1.6
2.3
u/ml
0.3
0.3
—
9
24
(3018095) Leukocytes [#/volume] in Urine
84
537
1.98
5.09
3.7
3.5
e6/l
80.7
91.3
0.08
66
378
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
23
5.00
5.08
1.7
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
24
89
2.93
5.06
1.9
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
140
1083
1.99
4.65
3.9
3.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
5
14.43
4.61
1.6
1.4
umol/l
29.4
28.2
—
7
5
(3012516) Albumin [Mass/volume] in Urine
78
500
1.92
4.59
3.1
3.3
mg/l
41.7
53.8
0.28
58
326
(3020682) Albumin/Creatinine [Ratio] in Urine
82
536
1.90
4.54
3.9
4.1
mg/mmol
10.4
7.0
0.34
56
344
(3044889) 12 lead EKG panel
149
1184
2.03
4.50
5.0
3.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
61
363
1.98
4.44
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
43
226
2.15
4.36
1.5
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
65
402
1.92
4.20
4.0
3.5
estimate
0.0
0.0
0.00
25
121
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
20
75
2.85
4.13
13.8
8.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
28
4.10
4.03
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
58
352
1.91
3.94
1.9
1.7
mg/l
1.5
1.1
0.82
46
272
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
8
11
7.52
3.89
1.1
1.3
mmol/l
7.0
—
—
8
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
29
3.96
3.86
1.3
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
25
4.16
3.74
6.3
2.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
57
350
1.88
3.71
4.1
4.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
125
2.34
3.68
6.9
2.0
ml/min/173m2
74.7
64.9
1.00
15
49
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
31
3.70
3.53
1.4
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
86
608
1.73
3.46
4.2
3.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
91
656
1.71
3.40
4.2
3.4
ng/l
37.7
42.0
0.09
72
462
(3041096) Erythrocytes [Presence] in Urine by Automated
65
429
1.77
3.31
3.8
3.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
184
1645
2.57
3.26
33.9
11.6
mg/l
35.0
22.5
4.72
170
1242
(3026008) Bacteria identified in Urine by Culture
63
418
1.74
3.13
2.8
3.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
16
5.16
3.08
1.4
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
8
7.69
3.07
1.3
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
157
2.07
3.05
1.6
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
12
6.00
3.04
1.3
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
158
2.06
3.00
1.7
1.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
5
10.21
2.99
1.2
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
5
10.21
2.99
4.6
2.2
ug/l
0.6
1.1
—
5
5
(3049717) Cytology report of Urine Cyto stain
13
46
2.95
2.98
2.4
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
39
229
1.87
2.87
1.7
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
18
4.58
2.82
1.3
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
24
123
2.08
2.58
6.2
7.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
89
2.25
2.54
1.8
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
12
5.12
2.42
1.0
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
52
350
1.66
2.39
1.6
1.7
pmol/l
463.1
428.0
0.23
42
289
(3035350) Ketones [Presence] in Urine by Test strip
97
762
1.53
2.30
4.0
3.5
estimate
0.0
0.0
0.00
29
125
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
175
1583
1.87
2.22
29.9
10.6
ml/min/173m2
82.6
79.9
1.07
166
1273
(3021601) Nitrite [Presence] in Urine by Test strip
97
767
1.52
2.20
5.2
4.8
estimate
0.0
0.0
0.00
28
125
(3022145) Colonoscopy Study observation
26
146
1.90
2.19
1.2
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
19
3.78
2.17
1.6
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
98
780
1.51
2.14
4.0
3.5
estimate
0.0
0.0
0.00
27
120
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
15
4.09
2.05
1.5
2.2
pg
29.2
34.3
—
6
15
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
21
3.42
1.98
1.3
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
19
100
2.00
1.93
3.3
4.9
%
0.0
0.0
—
6
22
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
38
249
1.65
1.92
2.7
3.0
e6/l
1.8
2.3
0.22
18
129
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
86
678
1.47
1.91
2.2
1.9
pmol/l
87.4
94.0
0.71
55
354
(3000494) Fungus identified in Specimen by Culture
29
178
1.74
1.86
1.5
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
23
3.12
1.81
1.6
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
18
3.40
1.76
1.7
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
23
134
1.81
1.75
3.2
2.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
24
2.98
1.74
2.9
2.8
e9/l
3.9
4.8
—
7
24
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
25
2.86
1.66
3.1
3.6
%
56.4
57.4
—
7
25
(3013512) EKG study
64
488
1.46
1.65
5.1
3.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
139
1222
1.46
1.63
3.5
4.1
mm/h
13.5
10.7
1.04
124
1114
(40768793) Breast Pathology biopsy report
5
14
3.63
1.62
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
26
2.75
1.59
1.0
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
140
1236
1.45
1.57
5.2
3.8
pmol/l
14.5
14.8
0.65
134
1112
(3017181) Myelocytes/100 leukocytes in Blood
19
108
1.84
1.57
3.3
4.7
%
0.7
0.6
—
7
26
(44806118)
5
15
3.39
1.53
1.2
1.4
—
—
—
0
0
(44790047)
5
15
3.39
1.53
1.2
1.4
—
—
—
0
0
(44790049)
5
15
3.39
1.53
1.2
1.4
—
—
—
0
0
(44790048)
5
15
3.39
1.53
1.2
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
154
0.43
1.50
2.0
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
28
2.55
1.46
1.4
2.3
%
51.2
61.9
—
7
28
(3026389) Candida sp identified in Specimen by Organism specific culture
5
16
3.18
1.44
1.2
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
22
2.78
1.44
5.0
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
43
311
1.49
1.43
1.9
1.7
nmol/l
1186.7
1135.9
0.14
37
234
(3002032) Base excess in Venous blood by calculation
25
159
1.65
1.43
3.8
3.4
mmol/l
1.8
2.0
0.06
19
121
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
28
184
1.61
1.41
1.8
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
25
160
1.64
1.40
3.8
3.4
kpa
5.7
5.8
0.27
25
154
(3007853) Bacteria identified in Skin by Aerobe culture
28
185
1.60
1.38
2.0
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
148
0.45
1.38
1.1
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
18
105
1.79
1.38
6.6
4.2
kpa
5.5
5.2
0.81
18
97
(3024354) Oxygen [Partial pressure] in Venous blood
21
129
1.70
1.36
4.1
2.7
kpa
4.7
4.3
0.28
21
122
(3002179) Metamyelocytes/100 leukocytes in Blood
17
98
1.80
1.36
2.7
5.0
%
0.3
0.3
—
6
19
(3017143) Hepatitis C virus Ab [Presence] in Serum
25
162
1.62
1.34
1.8
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
48
2.14
1.30
1.7
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
8
35
2.34
1.28
6.3
2.8
mmol/l
26.2
24.0
—
8
29
(3012544) pH of Venous blood
25
166
1.58
1.22
4.4
3.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
38
277
1.46
1.22
2.5
2.7
e6/l
0.8
1.0
0.28
18
156
(3021440) Promyelocytes/100 leukocytes in Blood
17
103
1.71
1.17
3.6
4.8
%
0.0
0.1
—
6
24
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
17
266
0.61
1.17
1.1
1.2
u/ml
1.5
9.7
—
9
101
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
114
0.42
1.16
2.2
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
43
325
1.41
1.14
3.7
3.7
ng/l
129.1
359.0
0.85
30
261
(40761511) CBC panel - Blood by Automated count
183
1738
1.66
1.13
34.6
11.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
165
1538
1.43
1.08
5.6
4.5
mu/l
2.0
2.7
0.44
152
1394
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
22
2.30
1.04
1.2
1.8
—
—
—
0
0
(3019225) pH of Specimen
22
149
1.54
1.00
10.9
3.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
13
78
1.71
0.94
6.5
8.6
mmol/l
25.5
24.9
0.17
13
71
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
86
1.68
0.93
2.9
2.1
%
0.9
1.3
1.03
14
86
(3025941) Bacteria identified in Stool by Culture
13
79
1.69
0.90
1.6
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
44
1.85
0.87
1.7
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
45
1.81
0.85
1.4
2.7
mg/l
1.6
1.5
—
8
40
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
13
82
1.63
0.80
3.1
4.0
mmol/l
24.6
24.7
0.01
13
71
(3026493) Urate [Moles/volume] in Serum or Plasma
52
429
1.29
0.79
2.3
2.4
umol/l
354.4
9170.4
2.26
46
370
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.2
—
207.5
—
0
13
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
27
0.00
0.78
0.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
132
0.59
0.76
1.0
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
160
1511
1.30
0.73
30.2
12.6
%
38.4
40.4
2.08
117
1076
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
109
1.51
0.73
1.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
174
1663
1.37
0.73
7.5
4.6
mmol/l
6.8
6.0
6.61
168
1506
(3004588) Protein electrophoresis panel - Serum or Plasma
15
101
1.52
0.72
2.2
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
44
363
1.27
0.67
4.3
3.7
kg/l
1.0
1.0
2.18
11
56
(1761482) Bacteria [#/volume] in Urine by Culture
8
50
1.62
0.62
4.1
3.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
30
1.68
0.62
1.8
2.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
21
0.00
0.60
0.0
1.3
—
63.7
—
0
15
(3028707) Methadone [Presence] in Urine by Screen method
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
35
1.74
0.58
4.7
2.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
5
87
0.56
0.57
1.2
1.2
u/ml
115.6
186.7
—
5
76
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
125
0.63
0.56
3.0
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
82
1.49
0.56
8.7
4.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
60
1.52
0.55
1.8
2.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
136
0.65
0.53
3.0
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
19
144
1.35
0.53
2.4
2.4
ug/l
5.7
8.2
0.34
19
125
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
92
1.44
0.52
1.2
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
191
1.29
0.49
1.7
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
23
286
0.78
0.49
1.0
1.3
iu/ml
15.8
34.8
—
7
91
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
117
0.67
0.47
1.0
1.3
—
41.3
—
0
9
(3052851) Hemolysis interference index of Serum or Plasma
7
50
1.41
0.45
2.7
3.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
50
1.41
0.45
2.1
4.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
56
627
0.85
0.43
3.0
3.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
87
1.40
0.43
3.8
3.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
31
1.63
0.43
1.8
2.2
mmol/l
4.1
4.1
—
5
31
(3035285) Chloride [Moles/volume] in Venous blood
5
31
1.63
0.43
1.8
2.2
mmol/l
104.0
105.4
—
5
31
(3014051) Protein [Presence] in Urine by Test strip
5
31
1.63
0.43
2.2
2.2
—
—
—
0
0
(4010399)
10
138
0.71
0.42
1.1
1.4
—
—
—
0
0
(3015736) pH of Urine
67
605
1.16
0.42
4.1
3.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
15
0.00
0.41
0.0
2.3
—
13.4
—
0
15
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
10
71
1.43
0.40
8.6
5.0
mmol/l
24.9
25.1
—
10
65
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
66
1.38
0.39
1.0
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
13
99
1.34
0.36
2.2
2.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
76
0.65
0.36
1.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
44
1.37
0.34
1.2
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
40
353
1.17
0.33
3.3
3.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
55
1.28
0.30
1.6
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
41
1.23
0.22
1.2
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
262.6
—
0
11
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
7.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
50
1.21
0.20
1.3
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
70
663
1.09
0.19
3.9
3.7
ug/l
2.0
1.9
0.10
62
602
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
101
976
1.07
0.15
2.9
2.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
80
1.13
0.15
1.0
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
179
1.13
0.15
1.4
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
9
110
0.81
0.13
1.2
1.9
g/l
9.9
11.1
—
9
100
(3037522) Nuclear Ab [Titer] in Serum
19
210
0.89
0.13
1.2
1.3
titre
288.0
608.9
—
5
54
(3000492) Spirometry study
14
158
0.88
0.12
1.4
1.3
—
—
—
0
0
(4094501)
6
56
1.07
0.08
1.3
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
36
342
1.06
0.08
1.6
1.2
u/ml
2.7
2.0
0.17
13
100
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
61
0.82
0.08
1.4
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
8
93
0.85
0.07
2.1
2.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
9
100
0.90
0.06
1.3
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
207
1.07
0.06
16.5
6.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
140
1416
0.96
0.06
43.4
15.0
g/l
330.6
333.1
2.20
140
1407
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
36
374
0.95
0.05
2.5
2.5
ug/l
0.9
0.8
0.33
22
235
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
53
516
1.04
0.05
3.1
3.5
%
26.0
23.9
0.40
27
225
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
25
260
0.96
0.03
1.3
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
168
1690
0.96
0.03
4.8
4.7
mmol/l
4.3
4.6
4.90
162
1570
(36660697) Celiac disease serology panel - Serum
13
122
1.07
0.03
1.5
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
167
1679
0.97
0.02
4.6
4.6
mmol/l
1.4
1.5
1.82
161
1551
(3028026) IgM [Mass/volume] in Serum or Plasma
10
94
1.07
0.01
1.0
1.3
g/l
0.8
1.1
—
10
86
(46235355) HIV 1 and 2 tests - Meaningful Use set
22
226
0.97
0.00
2.0
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
30
304
0.98
0.00
1.5
1.3
g/l
2.5
2.6
0.13
18
184
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
163
1625
1.02
0.00
4.4
4.2
mmol/l
1.4
1.3
0.90
156
1490
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
22
218
1.01
0.00
3.8
4.8
%
33.7
30.5
0.46
16
141
(4211845)
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4015189)
0
8
0.00
0.00
0.0
3.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.1
—
2.5
—
0
8
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
1.4
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
9.5
—
0
7
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3000012) Reticulocyte production index
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
172
1720
1.00
0.00
5.0
5.2
mmol/l
2.5
2.8
4.00
163
1589
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
2.2
—
7.2
—
0
5
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
3.1
—
0
5
(4198724)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
26.6
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.5
—
0
5
(40768446) Kidney Pathology biopsy report
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
78
0.89
0.00
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
5
0.00
0.00
0.0
38.2
—
7.1
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_PANCREAS_NEUROENDOCRINE_EXALLC – Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).